Ovarian Cancer Clinical Trial

Connecting Audio and Radio Sensing Systems to Improve Care at Home

Summary

This is a proof-of-concept pilot randomized clinical trial to test the usability and feasibility of the innovative Audio + Radio (AURA) system to enhance personalized supportive care for cancer patients and caregivers during post-ostomy care transition.

View Full Description

Full Description

In this proof-of-concept study, our multidisciplinary team will conduct a pilot randomized clinical trial to test the feasibility of the innovative AUdio + RAdio (AURA) system to enhance personalized supportive care for cancer patients and caregivers during post-treatment care transition. The investigators will randomly assign 30 cancer patients with newly created ostomies for cancer treatment with curative intent and their primary caregivers to the AURA or usual care groups (30 patient-caregiver dyads, a total of 60 individuals). AURA is defined as a system that connects audio-based voice assistant devices with radiofrequency (RF) sensing technology to gather relevant patient information automatically, interactively, and with context-awareness and to store a patient's health records that otherwise had to be measured and entered manually into an electronic system. The users of this system will be the entire care team, consisting of the patient and their family members as well as the caregivers and healthcare providers at remote sites. The investigators will conduct pre- and post-assessments of quality of life (QOL) and patient-reported outcomes (PRO, symptoms) at baseline upon enrollment and 2 months later. If results indicate that the pilot trial is feasible, the investigators will design and conduct a definitive trial to examine the efficacy of AURA, a potentially scalable intervention that can be disseminated through oncology clinics nationwide to enhance post-treatment care for cancer patients with ostomies who transition from hospital professional care to self-management at home and their caregivers.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Phase I: The investigators will only be recruiting patients for this phase

Patients must:

have been surgically treated for colorectal or bladder cancer with curative intent;
have had an ostomy with curative intent for at least 90 days;
be able to read and speak English;
be 18 years or older;

Phase II: The investigators will be recruiting patients and caregivers as a dyad for this phase

Patients must:

have been surgically treated for colorectal or bladder cancer with curative intent;
be within one month of hospital discharge of a newly created ostomy with curative intent;
be able to read and speak English;
be 18 years or older;
have a caregiver who is willing to participate in the study;

Caregivers must:

be 18 years or older;
be able to read and speak English;
be identified as the primary caregiver by the patient;
have not themselves been diagnosed with cancer or received cancer treatment during the study (to ensure that patients and caregivers focus their efforts on care of the patient).

Exclusion Criteria

Patients and their caregivers will be excluded if they:

are unable to read, speak, or understand English;
have more than one type of ostomy;
have other cancer diagnosis (excluding non-melanomatous skin cancer); or
have cognitive impairment (assessed by the Short Portable Mental Status Questionnaire).

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

60

Study ID:

NCT05344950

Recruitment Status:

Recruiting

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of North Carolina at Chapel Hill
Chapel Hill North Carolina, 27599, United States More Info
Lixin Song, PhD
Contact
919-966-3612
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

60

Study ID:

NCT05344950

Recruitment Status:

Recruiting

Sponsor:


UNC Lineberger Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.